Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States

Annals of Internal Medicine

Volumn 156, Issue 5, 2012, Pages 340-349

  Wegwarth, Odette ^a   Schwartz, Lisa M ^b   Woloshin, Steven ^b   Gaissmaier, Wolfgang ^a   Gigerenzer, Gerd ^a  

^a MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENERAL PRACTITIONER; HEALTH STATISTICS; HOSPITAL PATIENT; HUMAN; INTERNET; MALE; OUTPATIENT; PERCEPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SURVIVAL RATE; UNITED STATES;

EID: 84857724590     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-5-201203060-00005     Document Type: Article

References (25)

1. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA. 2000;283:2975-2978. [PMID: 10865276]
2. Welch HG, Woloshin S, Schwartz LM, Gordis L, Gøtzsche PC, Harris R, et al. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) Study. Arch Intern Med. 2007;167: 2289-2295. [PMID: 18039986]
3. Folkman J, Kalluri R. Cancer without disease. Nature. 2004;427:787. [PMID: 14985739]
4. Mooi WJ, Peeper DS. Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med. 2006;355:1037-1046. [PMID: 16957149]
5. Serrano M. Cancer regression by senescence. N Engl J Med. 2007;356: 1996-1997. [PMID: 17494935]
6. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102:605-613. [PMID: 20413742]
7. Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer. J Natl Cancer Inst. 1990;82:825-835. [PMID: 2332901]
8. Harris Interactive Physician Panel. Accessed at www.harrisinteractive.com /MethodsTools/DataCollection/SpecialtyPanelsPanelDevelopment/PhysiciansPanel.aspx on 18 October 2010.
9. SEER Cancer Statistics Review. Accessed at http://seer.cancer.gov/csr /1975_2008/index.html on January 2009.
10. Centers for Disease Control and Prevention, Office of Surveillance, Epidemiology, and Laboratory Services, Behavioral Risk Factor Surveillance System. Prevalence and Trends Data: Nationwide (States, DC, and Territories)-2006. Prostate Cancer. Accessed at http://apps.nccd.cdc.gov/BRFSS/display.asp?cat=PC&yr=2006&qkey=4423&state=US on November 2011.
11. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-1328. [PMID: 19297566]
12. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-1319. [PMID: 19297565]
13. Studdert DM, Michelle M, Sage WM, DesRoches CM, Peugh J, Zapert K, et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA. 2005;293:2609-2617. [PMID: 15928282]
14. Studdert DM, Mello MM, Gawande AA, Gandhi TK, Kachalia A, Yoon C, et al. Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med. 2006;354:2024-2033. [PMID: 16687715]
15. Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(5 Suppl):1214-1228. [PMID: 15316908]
16. McGettigan P, Sly K, O'Connell D, Hill S, Henry D. The effects of information framing on the practices of physicians. J Gen Intern Med. 1999;14: 633-642. [PMID: 10571710]
17. Jain BP. Number needed to treat and relative risk reduction. Ann Intern Med. 1998;128:72-73. [PMID: 9424990]
18. Naylor CD, Chen, E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med. 1992;117:916-921. [PMID: 1443954]
19. Covey J. A meta-analysis of the effects of presenting treatment benefits indifferent formats. Med Decis Making. 2007;27:638-654. [PMID: 17873250]
20. Eddy DM. Probabilistic reasoning in clinical medicine: problems and opportunities. In: Kahneman D, Slovic P, Tversky A, eds. Judgment under Uncertainty: Heuristics and Biases. Cambridge, UK: Cambridge Univ Pr; 1982: 249-267.
21. Casscells W, Schoenberger A, Graboys TB. Interpretation by physicians of clinical laboratory results. N Engl J Med. 1978;299:999-1001. [PMID: 692627]
22. Bramwell R, West H, Salmon P. Health professionals' and service users' interpretation of screening test results: experimental study. BMJ. 2006;333:284.[PMID: 16840441]
23. Hoffrage U, Gigerenzer G. Using natural frequencies to improve diagnostic inferences. Acad Med. 1998;73:538-540. [PMID: 9609869]
24. Wegwarth O, Gigerenzer G. "There is nothing to worry about": gynecologists' counseling on mammography. Patient Educ Couns. 2011;84:251-256. [PMID: 20719463]
25. Wegwarth O, Gaissmaier W, Gigerenzer G. Deceiving numbers: survival rates and their impact on doctors' risk communication. Med Decis Making. 2011;31:386-394. [PMID: 21191123]